Clinical Trial Update: Autologous Hematopoietic Stem Cell Transplant in Neuromyelitis Optica [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating autologous hematopoietic stem cell transplant in Neuromyelitis Optica has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromyelitis Optica

Drugs mentioned

• Autologous hematopoietic stem cell transplant

Snippet

Sponsor: University of Calgary | Conditions: Neuromyelitis Optica | Phase 1, Phase 2 | Status: TERMINATED